Evidence map›Paper›PMID 40108706›Full record

ReviewJournal of medical case reports2025

Primary ovarian neuroendocrine neoplasia with concurrent large epithelial borderline ovarian tumor, coexistent with non-malignant pleural effusion and multiple uterine fibroids: a case report and review of the literature.

Mariam Mohsin, Rajani Dube, Dina Hamza, Mavra Ali, Heena Garg

Abstract readCase ReportsReview
In one paragraph

Review in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mariam MohsinDepartment of Obstetrics and Gynecology, Dubai Health Authority, Dubai, United Arab Emirates.
Rajani DubeDepartment of Obstetrics and Gynecology, RAK Medical and Health Sciences University, RAK Medical & Health Science University, Ras Al Khaimah, United Arab Emirates. rajani.dube@rakmhsu.ac.ae.ORCID http://orcid.org/0000-0002-1539-6162
Dina HamzaDepartment of Obstetrics and Gynecology, Dubai Health Authority, Dubai, United Arab Emirates.
Mavra AliDepartment of Obstetrics and Gynecology, RAK Medical and Health Sciences University, RAK Medical & Health Science University, Ras Al Khaimah, United Arab Emirates.
Heena GargDepartment of Obstetrics and Gynecology, Al Zahrawi Hospital, Ras Al Khaimah, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeuroendocrine neoplasms are a group of neoplasms often originating from the neuroendocrine cells in the gastrointestinal tract, pancreas, and respiratory tract. Neuroendocrine neoplasms rarely occur in female reproductive organs and less than a hundred cases of ovarian high-grade lesions have been reported in the literature so far. Fewer still are cases reported in the literature associated with a borderline epithelial tumor in the same ovary. Owing to the rarity of the condition, there is a lack of specific guidelines for staging, and optimal management of these tumors. CASE PRESENTATION: We are reporting a case of primary ovarian neuroendocrine neoplasm in association with an epithelial borderline tumor. She is a 50-year-old Filipino woman who presented with nonspecific symptoms. Initial imaging revealed a large mass with suspicion of widespread metastasis. However, further imaging and laparotomy revealed early-stage neuroendocrine neoplasm, a large borderline epithelial tumor, with no evidence of pulmonary metastasis, despite having pleural effusion. She was lost to follow-up, presented again after a year with evidence of residual disease/metastasis, and was treated with chemotherapy. DISCUSSION AND

conclusionThe case posed significant difficulty owing to a lack of typical symptoms at presentation, nonmalignant changes in lungs in imaging, and therapeutic challenges due to the noncompliance of the patient. This report highlights the importance of considering the combination of borderline tumors of the ovary with neuroendocrine carcinoma as a possible differential diagnosis in ovarian tumors, the use of imaging and specific bio-markers for early identification, timely treatment, and follow-ups.

Indexed as

Carcinoma, Ovarian EpithelialLeiomyomaNeuroendocrine TumorsOvarian NeoplasmsPleural EffusionFemaleHumansMiddle AgedTomography, X-Ray ComputedBorderline mucinous tumor of the ovaryGynecological NENNeuroendocrine neoplasmsOvarian neoplasmOvarian NETPrimary ovarian neuroendocrine tumor

Identifiers

PMID40108706
PMCPMC11921653

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.